TNF and inflammatory bowel disease: Although therapeutic drug monitoring (TDM), defined as the evaluation of levels of drug and anti-drug antibodies, has proven to be effective in optimizing anti-TNF therapy in maintenance phase of IBD, the studies are limited to monitoring levels in induction phase.